Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)
NCT00338780
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Lamivudine/ Placebo 100mg daily
Sponsor
Chinese University of Hong Kong
Collaborators
[object Object]